Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$4.39bn	n/a	n/a
MSBMesoblast	AU$2.74bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$1.17bn	n/a	n/a
PYCPYC Therapeutics	AU$1.04bn	n/a	n/a
RACRacura Oncology	AU$475.55m	n/a	n/a
CGSCogstate	AU$365.41m	23.91	0.89%
TTXTetratherix	AU$218.44m	n/a	n/a
DXBDimerix	AU$192.13m	n/a	n/a
NYRNyrada	AU$152.04m	n/a	n/a
PEBPacific Edge	NZ$178.87m	n/a	n/a
BXNBioxyne	AU$142.43m	16.58	n/a
ATXAmplia Therapeutics	AU$123.14m	n/a	n/a
ACWActinogen Medical	AU$117.92m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$111.41m	n/a	n/a
ILAIsland Pharmaceuticals	AU$100.89m	n/a	n/a
ATHAlterity Therapeutics	AU$97.88m	n/a	n/a
ALAArovella Therapeutics	AU$82.88m	n/a	n/a
LTPLtr Pharma	AU$73.57m	n/a	n/a
CYPCynata Therapeutics	AU$70.05m	n/a	n/a
IMMImmutep	AU$64.84m	n/a	n/a